News
Eli Lilly executives stated in a conference call that, at fixed exchange rates, revenue in the European region grew by over 100%, reflecting strong market demand for the diabetes drug Mounjaro
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments